Stay updated on Obinutuzumab in SLE: Clinical Trial
Sign up to get notified when there's something new on the Obinutuzumab in SLE: Clinical Trial page.

Latest updates to the Obinutuzumab in SLE: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedLatest update dated 2026-09-23 (version 57, with prior entry 2026-08-28) adds core study record sections—Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Documents, and Contacts/Locations. It also includes a Quality Control Review Has Not Concluded notice.SummaryDifference0.7%

- Check15 days agoChange DetectedA new revision entry, v3.7.0, was added to the study history and the older v3.6.6 entry was removed. This update changes the page's version log without modifying the underlying study data.SummaryDifference0.1%

- Check30 days agoChange DetectedResults Submitted was added to the study record history and No Results Posted was removed, indicating that the study's results have been submitted for posting.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page's revision label was updated to v3.6.6 from v3.6.5. This reflects a newer version of the page.SummaryDifference0.1%

- Check58 days agoChange DetectedThe study record history shows a revision update from v3.6.4 to v3.6.5, indicating a minor maintenance release to the page.SummaryDifference0.1%

- Check72 days agoChange DetectedThe revision label at the bottom of the study history page has been updated to v3.6.4, reflecting a newer page build. There are no visible changes to the study history content or layout.SummaryDifference0.1%

Stay in the know with updates to Obinutuzumab in SLE: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Obinutuzumab in SLE: Clinical Trial page.